Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001179110-11-012928

Options or other derivatives

  • EVP, Chief Legal Officer & Sec acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BELBEL CAESAR J EVP, Chief Legal Officer & Sec 2011-09-06 Grant or award · Stock Options (right to buy) +200,000 200,000 D
Loading xslF345X03/edgar.xml…